- Presentations
- 3
- Markets
- 1
Mekinist is a brand of Trametinib dimethyl sulfoxide marketed by Novartis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Trametinib dimethyl sulfoxide
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 0.05 mg/mL powder for oral solution, 0.5 mg tablet, 2 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Mekinist 0.05 mg/mL powder for oral solutionOral Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Mekinist 0.5 mg tabletOral Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Mekinist 2 mg tabletOral Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Mekinist
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.